We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Wisconsin Ginseng (Panax quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind Trial, N07C2.
- Authors
Barton, Debra L.; Liu, Heshan; Dakhil, Shaker R.; Linquist, Breanna; Sloan, Jeff A.; Nichols, Craig R.; McGinn, Travis W.; Stella, Philip J.; Seeger, Grant R.; Sood, Amit; Loprinzi, Charles L.
- Abstract
Background Safe, effective interventions to improve cancer-related fatigue (CRF) are needed because it remains a prevalent, distressing, and activity-limiting symptom. Based on pilot data, a phase III trial was developed to evaluate the efficacy of American ginseng on CRF. Methods A multisite, double-blind trial randomized fatigued cancer survivors to 2000mg of American ginseng vs a placebo for 8 weeks. The primary endpoint was the general subscale of the Multidimensional Fatigue Symptom Inventory–Short Form (MFSI-SF) at 4 weeks. Changes from baseline at 4 and 8 weeks were evaluated between arms by a two-sided, two-sample t test. Toxicities were evaluated by self-report and the National Cancer Institute’s Common Terminology Criteria for Adverse Events (CTCAE) provider grading. Results Three hundred sixty-four participants were enrolled from 40 institutions. Changes from baseline in the general subscale of the MFSI-SF were 14.4 (standard deviation [SD] = 27.1) in the ginseng arm vs 8.2 (SD = 24.8) in the placebo arm at 4 weeks (P = .07). A statistically significant difference was seen at 8 weeks with a change score of 20 (SD = 27) for the ginseng group and 10.3 (SD = 26.1) for the placebo group (P = .003). Greater benefit was reported in patients receiving active cancer treatment vs those who had completed treatment. Toxicities per self-report and CTCAE grading did not differ statistically significantly between arms. Conclusions Data support the benefit of American ginseng, 2000mg daily, on CRF over an 8-week period. There were no discernible toxicities associated with the treatment. Studies to increase knowledge to guide the role of ginseng to improve CRF are needed.
- Subjects
AMERICAN ginseng; FATIGUE (Physiology); CANCER treatment complications; PHYSIOLOGICAL effects of chemotherapy; CANCER patients; THERAPEUTICS
- Publication
JNCI: Journal of the National Cancer Institute, 2013, Vol 105, Issue 16, p1230
- ISSN
0027-8874
- Publication type
Article
- DOI
10.1093/jnci/djt181